NCT03935074

Superselective Intra-arterial Chemotherapy Treatment for Retinoblastoma- 5 Year Results From Turkey

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 30 (actual)
• Sponsor: Istanbul University - Cerrahpasa · Academic / Other
• Sex: All
• Age: 5 Months – 7 Years
• Healthy volunteers: —

Summary

Retrospective review of 5-year long term outcomes of superselective intra-arterial chemotherapy treatment in retinoblastoma in a single institute. The treatment outcomes, globe salvage rates and complications of superselective intra-arterial chemotherapy both for treating naive patients (primary treatment group) and for patients who received systemic chemotherapy previously (secondary treatment group) were evaluated.

Conditions

• Retinoblastoma

Interventions

Type	Name	Description
DRUG	intra-arterial administration of melphalan

Timeline

• Start date: 2016-08-30
• Primary completion: 2016-11-30
• Completion: 2016-11-30
• First posted: 2019-05-02
• Last updated: 2019-05-06

Locations

1 site across 1 country: Turkey (Türkiye)